Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-01 @ 9:10 PM
Study NCT ID:
NCT06453057
Status:
RECRUITING
Last Update Posted:
2025-02-17
First Post:
2024-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Solid Tumours
Sponsor:
Grit Biotechnology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-07
First Submit QC Date:
None
Study First Post Date:
2024-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-02-17
Last Update Post Date Type:
ACTUAL